Remote Patient Monitoring Enters a New Era

article image
ARTICLE SUMMARY:

Interest in remote patient monitoring is intensifying in the wake of the COVID-19 pandemic, as more healthcare shifts to home-based settings. This is the first in a series of articles on the future of RPM and how both established competitors and innovative start-ups are working to meet growing demand for remote care technologies. First up: a discussion with James Mault, MD, co-founder and CEO of BioIntelliSense.

Telemedicine and remote patient monitoring (RPM) have been pushed to the forefront during the COVID-19 health emergency and companies that operate in this field are experiencing unprecedented growth and demand for their products and services. As the pandemic accelerates the ongoing move toward digital health, a variety of remote care options will be needed to meet future demand. That opens the door not only for existing RPM competitors but also for a growing number of consumer tech companies and medtech start-ups seeking to make an impact in the remote healthcare marketplace with technologies ranging from fitness wearables to implantable sensors.

×

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?


Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.

All-Access

Questions?

We're here to help! Please contact us at: